Recombinant Activated Factor VII Safety in Trauma Patients: Results From the CONTROL Trial

Troponin-I as a prognosticator of mortality in severe sepsis patients

(2010) Jijo John et al.   JOURNAL OF CRITICAL CARE

Safety of Recombinant Activated Factor VII in Randomized Clinical Trials

(2010) Marcel Levi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of Recombinant Factor VIIa in US Military Casualties for a Five-Year Period

(2010) Charles E. Wade et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

Results of the CONTROL Trial: Efficacy and Safety of Recombinant Activated Factor VII in the Management of Refractory Traumatic Hemorrhage

(2010) Carl J. Hauser et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

Scientific and logistical challenges in designing the CONTROL trial: recombinant factor VIIa in severe trauma patients with refractory bleeding

(2009) Richard Dutton et al.   Clinical Trials

Thromboembolic complications following trauma

(2009) Daniel F. McLaughlin et al.   TRANSFUSION

The Effect of Recombinant Activated Factor VII on Mortality in Combat-Related Casualties With Severe Trauma and Massive Transfusion

(2009) Philip C. Spinella et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

Four Years of an Aggressive Prophylaxis and Screening Protocol for Venous Thromboembolism in a Large Trauma Population

(2009) Raeanna C. Adams et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE